Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Shirwan, Haval	University Of Missouri-Columbia United States	Developing a novel agonist of CD137 for cancer immunoprevention	5UG3CA290305-02	Altaf Mohammed, Ph.D.
Shu, Xiao-Ou	Vanderbilt University Medical Center United States	Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer	5R01CA227133-05	Matthew Young, Ph.D.
Shureiqi, Imad	University Of Michigan At Ann Arbor United States	ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism	5R01CA266223-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad	Commonspirit Health Research Institute United States	CIRI Oncology Research Alliance	3UG1CA189809-11S1	Vanessa A. White, M.P.H.
Sidransky, David	Johns Hopkins University United States	Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma	5R01CA265975-04	Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C	University Of Iowa United States	Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers	5R01CA267820-03	Nicholas Hodges, Ph.D.
Sigel, Keith Magnus	Icahn School Of Medicine At Mount Sinai United States	The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors	4R01CA256660-05	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M	University Of California, San Diego United States	Biomarker Validation in Pancreatic Cystic Neoplasms	5U01CA282272-03	Matthew Young, Ph.D.
Siminski, Suzanne M.	Frontier Sci & Technology Rsch Fdn, Inc United States	CASCADE Coordinating Center	5U24CA275417-04	Maria Silvina Frech, Ph.D., M.S.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis	5R01CA222900-06
Singal, Amit	Ut Southwestern Medical Center United States	Clinical Validation Center for Hepatocellular Carcinoma	5U01CA271887-04	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States	5U01CA230694-05
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules	4U01CA283935-03	Sidney Fu, M.D.
Siskind, Leah J	University Of Louisville United States	Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease	1R01CA305985-01	Marjorie Perloff, M.D.
Skates, Steven J	Massachusetts General Hospital United States	Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer	5U2CCA271871-03	Christos Patriotis, Ph.D., M.Sc.